Last Wednesday, the head of an AI tech company casually announced, in a long-winded post on X, a discovery that, if true, would represent a major breakthrough in biomedical research. Dario Amodei, CEO of Anthropic, wrote that his company’s large language model Claude had found “a molecular machine that we suspect could represent a new gene editing mechanism.”
So what does this “molecular machine” actually do? No one is entirely sure yet. But that hasn’t stopped tech bros from already upholding it as a new version of CRISPR, the enzyme-wielding tool that cuts up DNA like nobody’s business, sparking a revolution in ultra-precise genetic modification that has spanned research in everything from agriculture to cancer therapy. It’s no surprise its discoverers earned a Nobel Prize in Chemistry. If an AI program really just made a similar discovery, it would be big news.
